Toksični učinci Ustilago maydis i fumonizina B1 u štakora by Pepeljnjak, Stjepan et al.
Ustilago maydis is a facultative biotrophic basidiomycete, causing smut disease in
maize. A hallmark of the disease is the induction of plant tumours (galls) filled with
masses of black teliospores. Ustilago maydis infection can inhibit plant development,
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The toxicity of Ustilago maydis and the possible syner-
gism with fumonisin B1 (FB1) were studied in Fischer
rats by evaluating pathological changes and biochemical
parameters in blood serum (LDH, ALT, GGT, ChE) and
tissue homogenate of brain and liver (AChE, ChE, GGT,
ALP). One experimental group (US) consumed diet with
70% of U. maydis galls and the other group (US+FB1) was
fed pellets containing 70% of U. maydis galls and 1 mg of
FB1 per kg of diet for 17 days. Control group (C) con-
sumed standard pellets. During the trial, experimental
animals were more excited, showing hyperactivity. Body
mass gains slightly increased in both groups compared
to the control. Gross pathological changes in liver, lungs,
uterus and ovaries were more pronounced in the US+FB1
than in the US group. Specific catalytic activities of AChE
decreased by 61% and by 63% in the liver and brain ho-
mogenate of the US group (p < 0.05) compared to the
control, indicating neurotoxic activity of U. maydis. Also,
specific catalytic concentration of AChE and ALP was
significantly decreased in the liver of the US+FB1 group
(p < 0.05). Activity of LDH in the blood serum was in-
creased up to 166% and 165% in the US+FB1 group (p <
0.05) compared to the control and US group values, re-
spectively, which indicates that FB1 was responsible for
the disruption of cell membrane integrity. These findings
suggest that Ustilago maydis and FB1 showed neurotoxi-
city in Fischer rats, which could be related to the alka-
loids of U. maydis and disruption of sphingolipid meta-
bolism by FB1 activity.
Keywords: Ustilago maydis, fumonisin B1, neurotoxicity,
cytotoxicity
* Correspondence e-mail: jpetrik@pharma.hr; msegvic@net.hr
leading to necrosis, hyperplasia and hypertrophy of infected organs (1). Earlier studies
observed inflammation of the respiratory system, lung emphysema, neurotoxicity, liver
and kidney necrosis, hyperplasia of small intestine and reproductive toxicity in various
animals (rats, horses, cows, pigs, poultry) fed with Ustilago species (2–5). The corn smut
fungus produces several secondary metabolites including ustizein, guanacine, itaconic
and ustilagic acid, alkaloids ustilagin and trimethylamine (6–8), which could be related
to the described pathology in animals. The P4 strain of U. maydis secrets a toxin KP4, en-
coded by a fungal virus. This toxin was shown to inhibit the calcium channel activity in
mammalian cells (9). Nowadays, there is some disagreement on U. maydis toxicity. In
Mexico and other Latin American countries, U. maydis has been traditionally used as hu-
man food named huitlacoche (10). On the one side, there is the nutrient potential of U.
maydis galls that includes carbohydrates, proteins, fats, vitamins and minerals, and on
the other side, its possible toxic effect on animals and humans.
Fumonisin B1 (FB1) is a mycotoxin produced mainly by Fusarium verticillioides, a
common contaminant of maize and other grains (11). This mycotoxin has been associ-
ated with various diseases in animals and humans, including equine leukoencephalo-
malacia, porcine pulmonary edema, immunosuppression, liver and kidney toxicity, liver
cancer, and has been connected with human oesophageal carcinoma in Southern Africa
and China (12–16). A proposed mechanism of FB1 toxicity based on its ability to inhibit
the biosynthesis of ceramide and complex sphingolipids through inhibition of the en-
zyme ceramide synthase (17). Several studies in animals (rats, mice, rabbits, swine, hors-
es, fish) fed high and low doses of FB1 observed certain changes in haematological and
biochemical parameters, such as lower haematocrits, reduction of red and white blood
cell counts, abnormal erythrocyte formation, increase of liver enzyme activities, increase
of biochemical parameters of kidney injury and increase in serum cholesterol (18–22).
The importance of FB1 as a toxic agent has been well studied in various animal models,
especially rats, but its possible synergism with other co-occurring mycotoxins and/or
frequent fungal contaminants of maize, such as U. maydis, remains a poorly investigated
area.
The work reported here was undertaken to investigate the toxicological profile of U.
maydis in Fischer rats and its possible synergism with FB1 by evaluating pathological
changes and some biochemical parameters.
EXPERIMENTAL
Materials
Ustilago maydis galls were collected in maize-growing fields near Zagreb (Grane{i-
na) in February, 2003, one month before the experiment.
Fumonisin B1 was isolated and detected according to the established method by Pe-
peljnjak et al. (22). Briefly, F. vertocillioides (syn. moniliforme) cultures growing on YES
(yeast exstract 20 g, suchrose 40 g, sterile water 1000 mL) were homogenised and por-
tions of 50 mL were extracted with 50 mL acetonitrile/water (9:1) for 10 min and then
filtered. Filtrate (50 mL) was extracted with n-hexane (2 x 25 mL). Upper hexane phase
was discarded and the water-soluble phase, adjusted to pH 8–9 with 25 mL of saturated
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NaHCO3, was then shaken with 25 mL of chloroform for subsequent purification. Upper
water-soluble phase was partially evaporated at 80 °C and then concentrated in vacuum
by lyophilisation. Lyophilisate was dissolved in acetonitrile/water (1:1) and analysed
with an FB1 commercial sample on silica gel GF254. Plates were developed in acetonit-
rile/toluene/water (93:5:2). Visualisation of FB1 was performed under UV light (366 nm).
The white crystalline material was tested for purity by thin-layer chromatography on
silica gel GF254.
Animals and treatment
Fifteen adult female Fischer rats weighing approximately 200 g were obtained from
the Animal Unit of the Faculty of Pharmacy and Biochemistry, Zagreb, Croatia, and ho-
used five per cage. The rats were given food and water ad libitum (standard laboratory
pellets, declared not to contain mycotoxins, PLIVA d.d., Croatia). Animals were divided
in two experimental (n = 2 x 5) and one control (n = 5) group. First experimental group
(US) consumed diet containing 70% U. maydis galls homogenised with pellets; the sec-
ond experimental group (US+FB1) consumed diet containing 70% U. maydis galls and 1 mg
of FB1 per kilogram of diet (total FB1 amount = 2 mg kg–1 of b.m.); control group (C)
consumed standard pellets. Body weight was recorded on the first and the last day of
the experiment, which was terminated after 17 days.
Animals were sacrificed by cervical dislocation after light ether anaesthesia. Patho-
logical changes in the liver, kidneys, brain, lungs, spleen, intestine, heart, uterus and
ovaria in experimental groups were visually examined and compared to the control.
Experiment was ethically approved by the Ethics Committee of Faculty of Phar-
macy and Biochemistry, University of Zagreb.
Preparation of liver and brain tissue homogenates
Liver and brain tissues were used to make homogenates in 10 g L–1 concentrations.
Tissues were quickly excised and homogenised at 4 °C in an Ultra-Turrax homogenizer
in cold 0.32 mol L–1 sucrose buffered with 0.05 mol L–1 Tris-HCl medium supplemented
with phenylmethyl-sulphonyl-fluoride as a proteinase inhibitor, pH 7.4, two times at
12000 rpm for 30 s.
Analytical methods
Acetylcholinesterase (acetylcholine acetyl-hydrolase, AChE, EC 3.1.1.7) activity was
determined by a colorimetric assay. Enzyme activity was calculated via acetylcholine
(ACh) concentrations at the start (ACh 0.5 mmol L–1) and after substrate incubation in
phosphate buffered solution (pH 7.2) at 37 °C for 30 min. ACh concentration was esti-
mated by the method of Augustinsson (23). Cholinesterase (acylcholine acyl-hydrolase,
ChE, EC 3.1.1.8) activity was determined according to Ellman et al. (24). Gamma glu-
tamyl transferase (GGT, EC 2.3.2.2) activity was determined according to Szasz (25). The
activity of alkaline phosphatase (ALP, EC 3.1.3.1) was determined by the kinetic method
of McComb and Bowers (1972) on a Pye Unicam SP 8-100 UV/Vis spectrophotometer.
Lactate dehydrogenase (LDH, EC 1.1.1.27) activity was determined using 50 L of blood
serum and 2 mL of working reagent (61.43 mmol L–1 Tris buffer, 0.20 mmol L–1 NADH,
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pH 7.4) and 10 L of substrate (21.5 mmol L–1 pyruvate). Absorbances were measured at
340 nm every 30 s over a 5-min time period on the spectrophotometer. The activity of
alanine aminotransferase (ALT, EC 2.6.1.2) was determined by the UV kinetic method ac-
cording to IFCC recommendation, using a commercial test manufactured by Herbos
Dijagnostika. Protein concentrations in liver and brain homogenates were determined by
the method of Lowry et al. (26).
The data presented as mean values and standard deviation were statistically ana-
lysed by the Kruskal-Wallis test followed by a multiple comparison procedure (Dunns
test). The level of p < 0.05 was considered statistically significant for all tests performed.
RESULTS AND DISCUSSION
All animals survived to the end of the study. From the first to the seventh day, the
behaviour of animals was similar in each group while from the seventh day to the end of
experiment feed consumption was increased in experimental groups and animals were
more excited, showing hyperactivity. At the end of the study, body mass gains unsig-
nificantly increased in both experimental groups (Fig. 1). These findings could be attri-
buted to the nutrient potential of U. maydis (carbohydrates, proteins, fats), stimulation of
appetite and metabolism. Previous studies on Leghorn chickens also revealed an increase
in body mass after feeding 2.5–10% of U. maydis (4).
Gross examination of dissected organs (Table I) revealed significant pathological
changes in the liver, kidneys, brain, lungs, stomach, intestine, uterus and ovaries. Patho-
logical changes in the liver, lungs, uterus and ovaries were more pronounced in the
group treated with both U. maydis and FB1. In the chickens fed U. maydis only, a slight
chronic catarrh with hyperplasia of glandular stomach and small intestine was found
(4). Outbreaks of pneumonia in cattle in Bulgaria were described as a consequence of U.
maydis spores inhalation. The animals in these outbreaks had lung emphysema and a
mass of teliospores was found in their lungs. Convulsions and cerebral meningitis with
spores present in the brain were found in rats and dogs treated with U. maydis (2). In our
previous unpublished experiment done in 2001 with three Fischer rats fed the same
amount of U. maydis for 12 days, some severe neurotoxic symptoms were manifested
such as body stiffness, and the left-side twisted head of one animal. In the present study,
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Fig. 1. Effect of U. maydis and FB1 on body mass gain in Fischer rats (C – control group, US – group
treated with Ustilago maydis, US+FB1 – group treated with Ustilago maydis and fumonisin B1).
such symptoms were not observed in any animal probably due to lower toxic potential
of U. maydis. More severe symptoms were found in the liver, lungs, uterus and ovaries
of the US+FB1 group, which could be attributed to the synergistic effect of U. maydis and
FB1, which is known to induce hepatotoxicity, pulmonary oedema and reproductive tox-
icity in animals (20, 27, 28).
In order to examine the effects of U. maydis and FB1, we determined the catalytic ac-
tivities of AChE, ChE, ALT, ALP, GGT and LDH in liver and brain tissue homogenates
as well as in the blood serum of the experimental animals. In the liver tissue homoge-
nate, significant decreases in catalytic activity of AChE and ALP were found in both ex-
perimental groups and the US+FB1 group, respectively (p < 0.05) (Fig. 2). ChE and GGT
activities were not significantly different from the control values. In the brain tissue, sig-
nificant decreases of AChE and GGT activities were recorded only in the US group (p <
0.05) (Fig. 3). LDH significantly increased and ALT was significantly decreased in the
blood serum samples of the US+FB1 group (Table II). Our results showed that the spe-
cific catalytic activities of AChE in the liver and brain homogenate of the US group de-
creased by 61% and 63% compared to the control, respectively. Specific catalytic concen-
tration of this enzyme also decreased in the US+FB1 group liver homogenates. AChE is a
specific cholinesterase located in the synapse, especially on postsynaptic membrane, but it
can be also found in lungs, spleen and erythrocytes. Alkaloids and organophosphoric com-
pounds are well known inhibitors of AChE activity, but numerous molecules are modera-
tors of this enzyme as well. Inhibited activity of AChE results in increased concentration of
acetylcholine, which reflects on the experimental animal behaviour. The treated animals
seem hyperactive. Chronic inhibited activity of AChE can lead to neurological disorders.
Secondary metabolites of U. maydis include alkaloids, some of which could be considered
potentially toxic and they can influence, directly or indirectly, the activity of AChE.
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Table I. Gross pathological changes in Fischer rats fed U. maydis and FB1
Control US US+FB1
Liver compact, brown, normal dark brown, hyperaemic yellow discoloration, lipid
infiltration, hyperaemic
Kidney solid capsule, dark red,
normal
shrieked, hyperaemic shrieked, hyperaemic
Brain grey, visible capillaries,
no bleeding
hyperaemic hyperaemic
Heart normal normal normal























LDH is the enzyme of the cytoplasm and its increased activity in blood serum is
present in damaged plasmatic membranes of cells in different tissues. In this study, sig-
nificantly increased catalytic activities of LDH were found in the US+FB1 group (166%
and 165%), when calculated according to the control values and the US group values, re-
spectively. The activity of LDH is increased only in the US+FB1 group while the LDH ac-
tivity in the US group is almost equal to the control. This leads to the conclusion that FB1
is responsible for the disruption of cell membrane integrity. At the same time, U. maydis
shows no cytotoxic effects.
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Fig. 2. Specific catalytic activities of acetylcholinesterase (AChE), cholinesterase (ChE), gamma-glu-
tamyl transferase (GGT) and alkaline phosphatase (ALP) in liver tissue of control and treated rats.
Values are mean ± SD. Enzyme activity for AChE and ChE are given in mol min–1 per miligram of
protein  10–3. Enzyme activity for GGT and ALP are given in mol min–1 per miligram of protein.
* Statistical significance of the difference between treated and control rats at the confidence level p <
0.05 (C – control group, US – group treated with Ustilago maydis, US+FB1 – group treated with Usti-
lago maydis and fumonisin B1).

























Fig. 3. Specific catalytic activities of acetylcholinesterase (AChE), cholinesterase (ChE), gamma-glu-
tamyl transferase (GGT) and alkaline phosphatase (ALP) in brain tissue of control and treated rats.
Values are mean ± SD. Enzyme activity for AChE and ChE are given in mol min–1 per miligram of
protein  10–3. Enzyme activity for GGT and ALP are given in mol min–1 per miligram of protein.
* Statistical significance of the difference between treated and control rats at the confidence level p <
0.05 (C – control group, US – group treated with Ustilago maydis, US+FB1 – group treated with Usti-
lago maydis and fumonisin B1).
This study was not foremost focused on the possibility that U. maydis could be in-
fected by mycoviruses but this fact ought to be taken into account. Mycoviruses general-
ly have double-stranded RNA genomes. Effects of these viruses on the fungal hosts are
usually uncertain but some are associated with debilitation of the host fungus, hypo-
virulence of the pathogen, or antifungal toxin production (29). Best characterised are the
killer-toxin-producing viruses of U. maydis. It was noted that the cells infected with each
of the three virus types produced diffusible proteinaceous toxins called KP1, KP4, and
KP6, respectively. The infected U. maydis cells produce inhibitory factors called killer to-
xins, which are pathogens for the other type of fungi or plant cells. However, there are
some killer toxins that are potentially pathogenic to mammalian cells. KP6, for exam-
ple, suggests a multimeric assembly with a central pore, which may be involved in dis-
ruption of potassium ion balance (30), while KP4 suggests a possible function as an ion
channel inhibitor (9).
Our results are in agreement with the research carried out by Rumora et al. (31) re-
garding cytotoxic and genotoxic effects of FB1 in the RK13 cell line. They have observed
increased activities of LDH and GLDH in the medium of FB1 treated cells. A very sensi-
tive parameter of liver tissue damage or hepatocellular injury is the increase of ALT ac-
tivity. However, in our study, the enzyme activity was not increased compared to the
control. This leads to the conclusion that the increase of LDH activities could be a result
of muscle tissue injury or of other organs and not the liver. Themur et al. (32) reported
unsignificant changes in ALT and GGT activity in serum observed in the rats treated
with a total of 319, 544 and 810 mg of FB1 per kilogram of b.m. for 30, 60 and 90 days
(32). In contrast to our results, the ALT activity was significantly increased in the serum
of rats and carp treated with FB1 (15 mg kg–1, 0.5 and 5 mg kg–1 of b.m., respectively) (22, 33).
CONCLUSIONS
Ustilago maydis and FB1 showed neurotoxicity in Fischer rats, which was indicated
by hyperactivity, brain hyperaemia and especially by decreased AChE activity. These
pathological changes could be related to the alkaloids of U. maydis and disruption of
sphingolipid metabolism by FB1 activity. Pathological changes in liver, lungs, uterus and
ovaries were more pronounced in the US+FB1 than in the US group, indicating possible
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Table II. Catalytic activities of lactate dehydrogenase (LDH), alanine aminotransferase (ALT),
gamma-glutamyl transferase (GGT), and cholinesterase (ChE) in blood serum of Fischer ratsa
Group n LDH (U/L) ALT (U/L) GGT (U/L) ChE (U/L)
C 5 1576.9  444.7 12.2  2.7 5.5  1.2 0.038  0.005
US 5 1586.6  350.4 10.2  2.2 6.3  1.1 0.037  0.011
US+FB1 5 2621.1  410.9b 6.9  1.6b 9.1  3.6 0.029  0.006
a Data are expressed as mean  SD.
b p < 0.05, significantly different from control values.
C – control group, US – group treated with Ustilago maydis, US+FB1 – group treated with Ustilago maydis and
fumonisin B1.
synergism. Increased activity of LDH in the serum was observed only in the US+FB1
group, which led to the conclusion that FB1 is responsible for cytotoxic effects. Such ac-
tivity of FB1 could increase the toxicity of U. maydis and other co-contaminants of fungal
origin that can be found in foods and feeds.
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S A @ E T A K
Toksi~ni u~inci Ustilago maydis i fumonizina B1 u {takora
STJEPAN PEPELJNJAK, JÓZSEF PETRIK i MAJA [EGVI] KLARI]
Toksi~no djelovanje kukuruzne snijeti Ustilago maydis i mogu}i sinergizam s fumo-
nizinom B1 (FB1) ispitivani su na {takorima soja Fischer. Toksi~ni u~inci su procijenjeni
na temelju organolepti~kog pregleda organa `rtvovanih `ivotinja i mjerenja biokemij-
skih parametara u serumu (LDH, ALT, GGT, ChE), te homogenatu tkiva jetre i mozga
(AChE, ChE, GGT, ALP). U jednoj pokusnoj skupini (US) `ivotinje su hranjene smjesom
biomase i snijeti masenog udjela 70%, dok je druga pokusna skupina (US+FB1) primala
smjesu biomase i snijeti masenog udjela 70%, te fumonizina B1 (1 mg po kilogramu hra-
ne) tijekom 17 dana. Kontrolna skupina je hranjena standardnom laboratorijskom hra-
nom. Tijekom pokusa `ivotinje su bile ekscitirane. Masa pokusnih `ivotinja bila je na
kraju pokusa ne{to ve}a u odnosu na kontrolnu skupinu. Uo~ene patolo{ke promjene na
jetri, plu}ima, uterusu i ovarijima bile su vi{e izra`ene u skupini US+FB1. Specifi~na ka-
taliti~ka aktivnost AChE u homogenatu jetre i mozga bila je zna~ajno smanjena u US
skupini (61, odnosno 63%) u odnosu na kontrolu (p < 0,05), {to ukazuje na neurotoksi-
~no djelovanje snijeti. Osim toga, zabilje`ena je zna~ajno smanjena aktivnost ovog enzi-
ma i ALP u homogenatu jetre US+FB1 skupine (p < 0,05). Specifi~na kataliti~ka aktivnost
LDH u serumu bila je zna~ajno pove}ana u US+FB1 skupini (165%, odnosno 166%) u
odnosu na US i kontrolnu skupinu, {to ukazuje da su o{te}enja stani~ne membrane re-
zultat djelovanja FB1. Neurotoksi~ni u~inci u {takora soja Fischer vjerojatno su poslje-
dica djelovanja alkaloida U. maydis i poreme}aja metabolizma sfingolipida uslijed djelo-
vanja FB1.
Klju~ne rije~i: Ustilago maydis, fumonizin B1, neurotoksi~nost, citotoksi~nost
Farmaceutsko-biokemijski fakultet Sveu~ili{ta u Zagrebu, Zagreb
348
S. Pepeljnjak et al.: Toxic effects of Ustilago maydis and fumonisin B1 in rats, Acta Pharm. 55 (2005) 339–348.
